Erythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: The multiethnic cohort

Cancer Causes and Control

Volumn 23, Issue 10, 2012, Pages 1693-1703

  Morimoto, Yukiko ^a   Conroy, Shannon M ^a   Ollberding, Nicholas J ^a   Henning, Susanne M ^a   Franke, Adrian A ^a   Wilkens, Lynne R ^a   Goodman, Marc T ^a   Hernandez, Brenda Y ^a   Marchand, Loïc Le ^a   Henderson, Brian E ^b   Kolonel, Laurence N ^c   Maskarinec, Gertraud ^d  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Fatty acids; Multiethnic population; Nested case control study; Non Hodgkin's lymphoma; Serum lipids

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN AMERICAN; CANCER RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; FEMALE; HISPANIC; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; LIPID COMPOSITION; LONGITUDINAL STUDY; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

AFRICAN AMERICANS; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; COHORT STUDIES; CONFIDENCE INTERVALS; ERYTHROCYTE MEMBRANE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS; FEMALE; HUMANS; LIPIDS; LOGISTIC MODELS; LYMPHOMA, NON-HODGKIN; MALE; PROSPECTIVE STUDIES; RISK; TRIGLYCERIDES;

EID: 84866995854     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0048-1     Document Type: Article

References (38)

1. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84:1-12
2. Kelley DS (2001) Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 17:669-673
3. James MJ, Gibson RA, Cleland LG (2000) Dietary polyunsatu-rated fatty acids and inflammatory mediator production. Am J Clin Nutr 71:343S-348S
4. Cross AJ, Lim U (2006) The role of dietary factors in the epidemiology of non-Hodgkin's lymphoma. Leuk Lymphoma 47:2477-2487
5. Calder PC, Grimble RF (2002) Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 56(Suppl 3):S14- S19
6. Cvetkovic Z, Vucic V, Cvetkovic B et al (2010) Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma. Ann Hematol 89:775-782
7. Zhang S, Hunter DJ, Rosner BA et al (1999) Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. J Natl Cancer Inst 91:1751-1758
8. Zheng T, Holford TR, Leaderer B et al (2004) Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol 159:454-466
9. Purdue MP, Bassani DG, Klar NS, Sloan M, Kreiger N (2004) Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case-control analysis. Cancer Epidemiol Biomark Prev 13:1665-1676
10. Chiu BC, Cerhan JR, Folsom AR et al (1996) Diet and risk of non-Hodgkin lymphoma in older women. JAMA 275:1315-1321
11. Skibola CF (2007) Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomark Prev 16:392-395
12. Morton LM, Wang SS, Cozen W et al. (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112: 5150-5160
13. Arab L, Akbar J (2002) Biomarkers and the measurement of fatty acids. Public Health Nutr 5:865-871
14. Fuhrman BJ, Barba M, Krogh V et al (2006) Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab 50:95-102
15. Lim U, Gayles T, Katki HA et al (2007) Serum high-density lipoprotein cholesterol and risk of non-hodgkin lymphoma. Cancer Res 67:5569-5574
16. Jacobs EJ, Newton CC, Thun MJ, Gapstur SM (2011) Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort. Cancer Res 71:1763-1771
17. Kolonel LN, Henderson BE, Hankin JH et al (2000) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151:346-357
18. Park SY, Wilkens LR, Henning SM et al (2009) Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control 20:211-223
19. Maskarinec G, Erber E, Gill J, Cozen W, Kolonel LN (2008) Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort. Cancer Epidemiol Biomark Prev 17:196-203
20. Turner JJ, Morton LM, Linet MS et al (2010) InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 116:e90-e98
21. Bagga D, Capone S, Wang HJ et al (1997) Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst 89:1123-1131
22. Friedwald WT, Levy RI, Frederickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 18:527-534
23. Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin's lymphoma. Oncogene 23:6524-6534
24. Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129:125-137
25. Fortuny J, De SS, Becker N et al (2006) Statin use and risk of lymphoid neoplasms: results from the European case-control study EPILYMPH. Cancer Epidemiol Biomark Prev 15:921-925
26. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (2001) JAMA 285:2486-2497
27. Godley PA, Campbell MK, Miller C et al (1996) Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma. Cancer Epidemiol Biomark Prev 5:115-119
28. Hodson L, Skeaff CM, Fielding BA (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a bio-marker of dietary intake. Prog Lipid Res 47:348-380
29. Riediger ND, Othman RA, Suh M, Moghadasian MH (2009) A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109:668-679
30. Ahn J, Lim U, Weinstein SJ et al (2009) Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomark Prev 18:2814-2821
31. Jafri H, Alsheikh-Ali AA, Karas RH (2010) Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol 55:2846-2854
32. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152-1160
33. van Duijnhoven FJ, Bueno-de-Mesquita HB, Calligaro M et al (2011) Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 60:1094-1102
34. Esteve E, Ricart W, Fernandez-Real JM (2005) Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 24:16-31
35. McGrowder D, Riley C, Morrison EY, Gordon L (2011) The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol 2011:496925
36. Kontush A, de Faria EC, Chantepie S, Chapman MJ (2005) A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 182:277-285
37. Erber E, Lim U, Maskarinec G, Kolonel LN (2009) Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort. Int J Cancer 125:1440-1445
38. Erber E, Maskarinec G, Gill JK, Park SY, Kolonel LN (2009) Dietary patterns and the risk of non-Hodgkin lymphoma: the Multiethnic Cohort. Leuk Lymphoma 50:1269-1275